4th Annual Gene Therapy for Ophthalmic Disorders Summit

Join us at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit, where we bring together the brightest minds in biopharma and academia to revolutionize the treatment of eye diseases. This premier event is the nexus between groundbreaking preclinical research and cutting-edge clinical development, shaping the future of ophthalmology.
With gene therapy at the forefront of innovation, we are witnessing an exciting transformation in the treatment of visual impairment. With over 100 active preclinical and clinical programs, along with promising results from clinical trials targeting both rare and common diseases, this summit is your gateway to the latest advancements in the field.
Over three insightful days, you will have the opportunity to engage with 30+ expert speakers who are driving progress in ophthalmic gene therapy. They will present groundbreaking data, lead dynamic panel discussions, and facilitate in-depth sessions addressing the key challenges we face. Whether you are focused on rare or common eye diseases, this event caters to your specific needs.
Our comprehensive agenda will help you:
1. Define relevant preclinical and clinical endpoints: Gain valuable insights into establishing meaningful endpoints for your research, ensuring that your gene therapy programs effectively address the needs of patients and regulators.
2. Explore novel routes of administration to the front and back of the eye: Discover innovative techniques for delivering gene therapies directly to the target areas of the eye, unlocking new possibilities for effective treatment.
3. Improve the translatability of your preclinical models: Enhance the predictive power of your preclinical models and bridge the gap between research findings and clinical outcomes, enabling more accurate projections of safety and efficacy.
By registering for the 2023 summit, you will gain access to keynote plenaries featuring industry-leading figures in gene therapy. Engage in focused discussions that tackle the most pressing challenges faced by your programs. Connect with over 130 peers and take advantage of invaluable networking opportunities. Leave armed with the actionable tools, insights, and connections you need to advance your work in ophthalmology.
As the field of ophthalmic gene therapy continues to evolve, it is crucial to stay informed about the latest developments. Join us at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit and become part of the transformation shaping the future of eye disease treatment.